Clinical Remission in Oral Corticosteroid (OCS)-dependent Patients with Severe Asthma: An Analysis of the ANDHI-IP and PONENTE Trials

Andrew Menzies-Gow; Renaud Louis; Anat  Shavit; David Price; Justin  Kwiatek; Borja G. Cosio; David L  Cohen; Nanna  Keeling; Tim Harrison

Clinical Remission in Oral Corticosteroid (OCS)-dependent Patients with Severe Asthma: An Analysis of the ANDHI-IP and PONENTE Trials

Andrew Menzies-Gow, Renaud Louis, Anat Shavit, David Price, Justin Kwiatek, Borja G. Cosio, David L Cohen, Nanna Keeling, Tim Harrison

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Publication status	Accepted/In press - 4 Apr 2023
Event	2023 ATS International Conference - Washington, D.C. , Washington D.C. , UNITED STATES Duration: 19 May 2023 → 24 May 2023 https://conference.thoracic.org/

Conference

Conference	2023 ATS International Conference
Country/Territory	UNITED STATES
City	Washington D.C.
Period	19/05/23 → 24/05/23
Internet address	https://conference.thoracic.org/

Cite this

@conference{a753cb04da07488e87097d37af51bd5f,

title = "Clinical Remission in Oral Corticosteroid (OCS)-dependent Patients with Severe Asthma: An Analysis of the ANDHI-IP and PONENTE Trials ",

author = "Andrew Menzies-Gow and Renaud Louis and Anat Shavit and David Price and Justin Kwiatek and Cosio, {Borja G.} and Cohen, {David L} and Nanna Keeling and Tim Harrison",

note = "Funding: This study was funded by AstraZeneca (Cambridge, UK).; 2023 ATS International Conference ; Conference date: 19-05-2023 Through 24-05-2023",

year = "2023",

month = apr,

day = "4",

language = "English",

url = "https://conference.thoracic.org/",

}

TY - CONF

T1 - Clinical Remission in Oral Corticosteroid (OCS)-dependent Patients with Severe Asthma

T2 - 2023 ATS International Conference

AU - Menzies-Gow, Andrew

AU - Louis, Renaud

AU - Shavit, Anat

AU - Price, David

AU - Kwiatek, Justin

AU - Cosio, Borja G.

AU - Cohen, David L

AU - Keeling, Nanna

AU - Harrison, Tim

N1 - Funding: This study was funded by AstraZeneca (Cambridge, UK).

PY - 2023/4/4

Y1 - 2023/4/4

M3 - Abstract

Y2 - 19 May 2023 through 24 May 2023

ER -